Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
01/2011
01/04/2011CA2142575C Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
01/04/2011CA2132103C Encoded combinatorial chemical libraries
01/04/2011CA2129899C Dual carrier immunogenic construct
01/04/2011CA2101774C Test and model for alzheimer's disease
01/04/2011CA2068654C Varicella-zoster virus antigen
01/03/2011CA2680967A1 Method and device for monitoring a zone of a metal
01/02/2011CA2708640A1 Amplified labeled conjugate for use in immunoassays
01/02/2011CA2708637A1 Capillary driven assay device and its manufacture
01/02/2011CA2708589A1 Assay device comprising serial reaction zones
12/2010
12/30/2010US20100333239 Methods using acyl-coa binding proteins to enhance low-temperature tolerance in genetically modified plants
12/30/2010US20100333217 Screening method for the composition for prevention or treatment of osteoporosis and metabolic bone disease using tallyho/jngj mouse
12/30/2010US20100333216 Non-human gene-disrupted animal with disrupted Adam11 gene
12/30/2010US20100332417 Methods for the detection and quantitation of the p95 component of her2/neu (erbb2)
12/30/2010US20100332149 Method and system for remote monitoring of fluid quality and treatment
12/30/2010US20100332144 Analysis apparatus and measurement unit
12/30/2010US20100332143 Method, Computer Program Product and System for Enabling Clinical Decision Support
12/30/2010US20100332141 Analyzer apparatus and methods for lung disease
12/30/2010US20100331653 Analyte Meter with a Moveable Head and Methods of Using the Same
12/30/2010US20100331647 Long term analyte sensor array
12/30/2010US20100331611 Embryo implantation
12/30/2010US20100331536 CA125 gene and its use for diagnostic and therapeutic interventions
12/30/2010US20100331280 Modulation of the Phospholipase A2 Pathway as a Therapeutic
12/30/2010US20100331269 Triterpenes derivatives and uses thereof as antitumor agents or anti-inflammatory agents
12/30/2010US20100331251 Polypeptides homologous to vegf and bmp1
12/30/2010US20100331233 Crystal of xpa and ercc1 complex and uses thereof
12/30/2010US20100331217 Substrate preparation process
12/30/2010US20100331214 siRNA Targeting Survivin
12/30/2010US20100331213 Microparticles with enhanced covalent binding capacity and their uses
12/30/2010US20100331206 Compositions and methods for early pregnancy diagnosis
12/30/2010US20100331203 Aromatase expression predicts survival in women with non-small cell lung cancer
12/30/2010US20100331201 Protein biochip for the differential screening of protein-protein interactions
12/30/2010US20100331200 Post translational modification pattern analysis
12/30/2010US20100331199 Method for the detection and/or enrichment of analyte proteins and/or analyte peptides from a complex protein mixture
12/30/2010US20100331195 Sequencing Nucleic Acid Polymers with Electron Microscopy
12/30/2010US20100331192 Surface display of recombinant proteins in lower eukaryotes
12/30/2010US20100330706 Probe immobilization and signal amplification for polymer-based biosensor
12/30/2010US20100330705 Immunological Test Element with Improved Control Zone
12/30/2010US20100330704 Composite particle, method for producing the same, dispersion solution, magnetic biosensing apparatus and magnetic biosensing method
12/30/2010US20100330703 Assays involving colorimetric and other signaling
12/30/2010US20100330702 Ultrasensitive detection of biomolecules using immunoseparation and diffractometry
12/30/2010US20100330701 Use of heat-resistant biotin-binding protein, and solid support having the protein attached thereto
12/30/2010US20100330700 Substrate for assaying beta-glucan and/or endotoxin and assay method
12/30/2010US20100330699 Apparatus and method for the detection of liquids or substances from liquids, and use of said apparatus
12/30/2010US20100330698 Detection of target components with the help of indicator particles
12/30/2010US20100330697 Complexes of trpc domains and sestd1 domains and methods and uses involving the same
12/30/2010US20100330696 Method of diagnosing endometriosis in human subjects
12/30/2010US20100330686 Nanosensor for sugar detection
12/30/2010US20100330685 Diaminorhodamine derivative
12/30/2010US20100330684 Diagnostic device and method
12/30/2010US20100330683 Method for quantifying oxidative stress caused by different biological pathways
12/30/2010US20100330681 SELECTIVE DETECTION OF Hg2+ BY CALIX[4]ARENES
12/30/2010US20100330679 Device and method for measuring the water activity of foods
12/30/2010US20100330668 Interaction Between the VHL Tumour Suppressor and Hypoxia Inducible Factor, and Assay Methods Relating Thereto
12/30/2010US20100330667 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level
12/30/2010US20100330619 Direct multiplex characterization of genomic dna
12/30/2010US20100330613 Methods for determining efficacy of chemotherapeutic agents
12/30/2010US20100330595 Diagnostic method for diseases by screening for hepcidin in human or animal tissues, blood or body fluids and therapeutic uses therefor
12/30/2010US20100330594 Early Detection of Diabetes
12/30/2010US20100330593 Methods and compositions for diagnosing neoplastic disease
12/30/2010US20100330592 Method for detecting truncated molecules
12/30/2010US20100330591 GPCR Expressing Cell Lines and Antibodies
12/30/2010US20100330590 Assays using chimeric t1r3 taste receptor polypeptides
12/30/2010US20100330589 Needle array assembly and method for delivering therapeutic agents
12/30/2010US20100330588 Method to quantify methyltransferase activity
12/30/2010US20100330587 Annexin Proteins and Autoantibodies As Serum Markers For Cancer
12/30/2010US20100330586 Method for identifying compounds for treatment of pain
12/30/2010US20100330585 Lateral flow assay system and methods for its use
12/30/2010US20100330584 Long wavelength fluorogenic intracellular ion indicators that are well retained in the cytosol
12/30/2010US20100330583 Compositions and methods for identification of PARP function, inhibitors, and activators
12/30/2010US20100330582 Method for production of novel nano silica particle and use of the nano silica particle
12/30/2010US20100330577 Methods for identification of an antibody or a target
12/30/2010US20100330574 Chimeric primers with hairpin conformations and methods of using same
12/30/2010US20100330572 Organic compounds
12/30/2010US20100330568 Assay and method for the assessment of responders and non-responders to nk cell modulation by immunoglobulin therapy
12/30/2010US20100330567 Dna markers for management of cancer
12/30/2010US20100330558 Gene Expression Profiling for Identification, Monitoring and Treatment of Cervical Cancer
12/30/2010US20100330557 Genomic coordinate system
12/30/2010US20100330555 Accuracy fluorescence in-situ hybridization assay of samples with apoptotic cells
12/30/2010US20100330554 Diagnostic kit for solid cancer and medicament for solid cancer therapy
12/30/2010US20100330115 Multivariable Antigens Complexed with Targeting Humanized Monoclonal Antibody
12/30/2010US20100330110 Therapeutic and diagnostic uses of antibody specificity profiles
12/30/2010US20100330095 Axl antibodies
12/30/2010US20100330092 Monoclonal antibody having neutralizing activity against mmp13
12/30/2010US20100330091 Immunoreactive glycoprotein gp19 ehrlichia canis
12/30/2010US20100330089 Anti-cd20 therapeutic compositions and methods
12/30/2010US20100330079 Biomarkder combinations for colorectal cancer
12/30/2010US20100330076 Immunoglobulin fc polypeptides
12/30/2010US20100330075 Monoclonal human tumor-specific antibody
12/30/2010US20100330074 Use of saccharides cross-reactive with bacillus anthracis spore glycoprotein as a vaccine against anthrax
12/30/2010US20100330072 Myostatin binding agents
12/30/2010US20100330070 Methods Of Making An Antibody And Compositions Thereof
12/30/2010US20100330067 Compounds and Methods for the Modulation of Toll-Like Receptor Function
12/30/2010US20100330066 Methods for Use with Baff Antagonists
12/30/2010US20100330044 Mesp1 as a master regulator of multipotent cardiovascular progenitor specification and uses thereof
12/30/2010US20100330043 Gpr125 as a marker for stem and progenitor cells and methods use thereof
12/30/2010US20100330037 Adenoviral systems and the uses thereof
12/30/2010US20100330001 Antibacterial compositions
12/30/2010US20100329992 Shiga toxin b-subunit as a vector for tumor diagnosis and drug delivery to gb3 expressing tumors
12/30/2010US20100329990 Luminescent markers
12/30/2010US20100329988 Method for Identifying Within a Mammal a DNA Encoding A Physiologically Active Polypeptide
1 ... 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 ... 3937